Merck asks FDA to authorize antiviral Covid pill for emergency use

Merck said it asked the FDA to authorize emergency use of its experimental antiviral pill to treat mild to moderate Covid-19 in adults at October 11, 2021 6:00 am ET

We supply Molnupiravir API and its starting material Cytidine and Uridine, if you're interested in them, kindly contact us at



2021-10-15 10:47